Tuesday, May 16th | Normandy Farm Hotel and Conference Center | Blue Bell, PA
The verticalization of drug development has long prohibited companies from taking a true end-to-end view of the development cycle. But eliminating these functional silos can enable sharper customer focus while also reducing development time, costs, and resource requirements.
TayganPoint explores this topic as well as the various pressures and industry trends prompting companies to consider a more horizontally integrated approach. We’ll discuss the results of our recent survey and continue the conversation with our panel of industry experts. We hope you can join us!
- Mark Ridge | Vice President Clinical Development Operations | CSL Behring
- Brian H. Lange, P.E. | Associate Vice President Supply Chain Management | Merck & Co.
- Linda Palczuk | Former VP, Mature Brands and Global Commercial Excellence | AstraZeneca
Contact your TayganPoint account manager for more information or register here: https://tayganpointevents.eventbrite.com